BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2018
View Archived Issues
FDA grants orphan drug designation to Proteostasis Therapeutics' PTI-428
Read More
Zymeworks to advance ZW-49 bispecific ADC
Read More
Positive topline data from phase III study of ALXN-1210 in patients with PNH
Read More
Patient enrollment ongoing in phase II study of BCD-089
Read More
PTC Therapeutics provides update on FIREFISH study in spinal muscular atrophy
Read More
NGM-282 shown to reduce liver fat in patients with NASH
Read More
Massive Bio announces SYNERGY-AI registry
Read More
FDA awards breakthrough therapy designation to erdafitinib for metastatic urothelial cancer
Read More
Ionis and Akcea enter worldwide license agreement to commercialize inotersen
Read More
Exelixis completes submission of sNDA in U.S. for Cabometyx in HCC
Read More
Abeona's ABO-202 receives FDA rare pediatic disease designation
Read More
Ovid Therapeutics' OV-101 given FDA fast track status
Read More
Medshine Discovery discloses novel PDE4 inhibitors
Read More
First patient dosed in phase III study of BCX-7353 for HAE
Read More
Novartis patents novel CFTR modulators
Read More
FDA accepts IND for phase II trial of BPN-14770 in fragile X syndrome
Read More
Nanjing TransThera Biosciences divulges novel FGFR inhibitors
Read More
Large trial finds mixed effects of carvedilol on chemotherapy-induced cardiotoxicity
Read More
Vernalis offers update on restructuring and enters formal sale process
Read More
Discuva presents novel antibiotics for bacterial infections
Read More
Calibr repurposes leprosy drug for the treatment of cryptosporidiosis
Read More
Medivir discovers compounds for RSV infection
Read More
Flagship Pioneering announces the launch of Foghorn Therapeutics
Read More
Lundbeck agrees to acquire Prexton Therapeutics
Read More
Novartis presents novel potent OGG1 inhibitor
Read More
CARB-X collaborates with Helixbind to support development of RaPID/BSI diagnostic test
Read More
K-mer-based transcriptomic approach identifies new antisense drug targets for Ewing's sarcoma
Read More
FDA approves CSL Behring's Hizentra in new indication
Read More